EP Biocomposites

EP Biocomposites Equity

The The Equity of EP Biocomposites (543595.BO) as of Oct 11, 2026 is 105.95 M INR. In the previous year, The Equity was 95.64 M INR — a change of 10.78% (higher).

Equity

105.95 MINR

YoY

10.78%

Last updated:

In 2025, EP Biocomposites's equity was 105.95 M INR, a 10.78% increase from the 95.64 M INR equity in the previous year.

The EP Biocomposites Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2020
285,000.00 INR
Jan 1, 2021
3.87 M INR
Jan 1, 2022
19.98 M INR
Jan 1, 2023
84.14 M INR
Jan 1, 2024
95.64 M INR
Jan 1, 2025
105.95 M INR
The EP Biocomposites Equity history
YEAREquityYoY
105.95 MINR+10.78%
95.64 MINR+13.66%
84.14 MINR+321.06%
19.98 MINR+417.05%
3.87 MINR+1,256.14%
285,000.00INR—
Access this data via the Eulerpool API
Get Free API Key

EP Biocomposites Stock analysis

What does EP Biocomposites do? EP Biocomposites is one of the most popular companies on Eulerpool.

Equity Details

Analyzing EP Biocomposites's Equity

EP Biocomposites's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding EP Biocomposites's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating EP Biocomposites's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

EP Biocomposites's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in EP Biocomposites’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about EP Biocomposites stock

The Equity of EP Biocomposites is 105.95 M INR in 2025.

The Equity of EP Biocomposites changed from 95.64 M INR to 105.95 M INR, representing a 10.78% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity EP Biocomposites since 2006 – with annual values, charts, and detailed analysis.

The Equity's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's EP Biocomposites historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — EP Biocomposites

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — EP Biocomposites